Search For "biocon"
FM Sitharaman and 4 Indians on Forbes' 100 Most Powerful Women list
Updated : 3 years, 3 months ago IST
Forbes had placed President of the European Commission Ursula von der Leyen on the top position of the 19th annual Forbes list of the World's 100 Most Powerful Women for her leadership during the Ukraine war.
Read More
Biocon Biologics appoints Shreehas Tambe as MD, CEO
Updated : 3 years, 3 months ago IST
Tambe takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on the board of Biocon Biologics.
Read More
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon subsidiary completes acquisition of Viatris for USD 3 billion
Updated : 3 years, 3 months ago IST
According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors, respectively.
Read More
Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capit
Updated : 3 years, 3 months ago IST
Bangalore (Karnataka) [India], November 24 (ANI/PRNewswire): Symbio Generrics India Private Limited (Symbio), a specialized Active Pharmaceutical Ingredients (API) & Intermediates manufacturing and marketing organization, announced today that it has completed an equity capital raise from
Read More
Biocon Q2FY23 Revenue at Rs 2,384 Cr., Up 23 percent; Core EBITDA at Rs 81
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30, 2022.
Read More
Cyril Amarchand Mangaldas advises on bulk share sale in Syngene Internatio
Updated : 3 years, 5 months ago IST
Mumbai (Maharashtra)/ New Delhi [India], October 10 (ANI/BusinessWire India): Cyril Amarchand Mangaldas advised Biocon Limited (Biocon), in relation to the sale of shares by Biocon Limited in Syngene International Limited (Syngene International), by way of a bulk trade on the stock exchanges
Read More
Delhi HC grants bail to joint drug controller of CDSCO
Updated : 3 years, 6 months ago IST
Delhi [India], September 6 (ANI): The Delhi High Court on Tuesday granted bail to the Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO) and a Biocon Biologics executive in a Rs 9 lakh bribery case.
Read More
The Indian Vitiligo Association celebrates World Vitiligo Day on June 25th
Updated : 3 years, 8 months ago IST
Faridabad (Haryana) [India], June 27 (ANI/NewsVoir): The India Vitiligo Association on June 25th, 2022 celebrated World Vitiligo Day by conducting an awareness camp in Faridabad, NCR at Kisan Bhawan.
Read More
CBI arrests Biocon Biologics official in bribery case; company denies alle
Updated : 3 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Central Bureau of Investigation (CBI) on Tuesday arrested Biocon Biologics Associate Vice President L Praveen Kumar in a bribery case involving Joint Drugs Controller S Eswara Reddy.
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More
SII announces strategic partnership with Biocon Biologics
Updated : 4 years, 5 months ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
Read More